France Molecular Diagnostics Market Insight
Published: 29 May 2026 | Report Format: Electronic (PDF)
The France Molecular Diagnostics market size is experiences at a 9.4% CAGR, driven by the rising demand for precision diagnostics, increasing chronic disease prevalence, and stronger investment in genomic medicine.
France Molecular Diagnostics Market Insights Forecasts to 2035
- The France Molecular Diagnostics Market Size Was Estimated at USD 1320.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 9.4% from 2025 to 2035
- The France Molecular Diagnostics Market Size is Expected to Reach USD 3242.02 Million by 2035
Notable Insights for France Molecular Diagnostics Market
- The PCR diagnostics segment controls the France molecular diagnostics market through its USD 540 million revenue stream during 2025. The segment holds the top position because PCR serves as the primary method for detecting infectious diseases and analyzing pathogens through sensitive molecular testing.
- The next-generation sequencing and liquid biopsy segment will achieve rapid expansion between 2018 and 2025 through an estimated CAGR of 11%. The healthcare sector experiences growth because precision oncology methods along with genomic medicine and biomarker discovery and personalized treatment planning systems drive its development.
- France holds about 10% of the European molecular diagnostics market because it maintains strong biotechnology research activities and operates with an advanced healthcare system.
- The French molecular diagnostics sector generates 42% of its income through PCR-based technologies because healthcare continues to focus on diagnosing infectious diseases and performing clinical molecular tests.
Download the eBook (ToC)
Why Buy This Report
- Gain comprehensive insights into the France molecular diagnostics market, including market size, growth trends, competitive landscape, and future forecast analysis shaping the precision healthcare and biotechnology industry.
- Analyze rising demand for molecular diagnostics across infectious disease testing, cancer diagnostics, genomic medicine, personalized healthcare, and rapid clinical testing applications in France.
- Identify high-growth investment opportunities through detailed evaluation of NGS technologies, liquid biopsy systems, AI-assisted diagnostics, companion diagnostics, and strategic developments influencing the France molecular diagnostics market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Molecular Diagnostics market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Molecular Diagnostics Market
- Roche Diagnostics
- QIAGEN
- Abbott Laboratories
- Thermo Fisher Scientific
- BioMérieux
- Danaher Corporation
- Hologic Inc.
- Siemens Healthineers
- Illumina Inc.
- Agilent Technologies
- Cepheid
- Becton Dickinson (BD)
- Others
Recent Developments:
- In March 2025, healthcare providers and diagnostic laboratories in France accelerated adoption of AI-assisted molecular diagnostic platforms designed to improve precision testing and faster clinical decision-making.
- In February 2025, biotechnology companies expanded development of liquid biopsy and next-generation sequencing technologies for early cancer detection and personalized oncology treatment planning.
Market Segmentation:
France Molecular Diagnostics Market, By Technology
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- In Situ Hybridization
- DNA Microarrays
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- CRISPR-Based Diagnostics
- Others
France Molecular Diagnostics Market, By Application
- Infectious Disease Diagnostics
- Oncology Testing
- Genetic Testing
- Blood Screening
- Prenatal Diagnostics
- Neurological Disease Diagnostics
- Cardiovascular Disease Testing
- Others
France Molecular Diagnostics Market, By Product Type
- Instruments
- Reagents and Kits
- Software and Analytics Solutions
- Consumables
- Others
Expert Views:
The France molecular diagnostics market is expected to grow rapidly, driven by next-generation sequencing, liquid biopsy expansion, AI-powered diagnostics, and precision oncology advancements. Companies focusing on diagnostic accuracy, genomic innovation, clinical scalability, regulatory compliance, and AI-integrated healthcare solutions will strengthen long-term competitive positioning.
Author: Sanket and Pranali By Spherical Insights and Consulting